These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance. Gould IM; David MZ; Esposito S; Garau J; Lina G; Mazzei T; Peters G Int J Antimicrob Agents; 2012 Feb; 39(2):96-104. PubMed ID: 22196394 [TBL] [Abstract][Full Text] [Related]
4. Alternative therapies in Staphylococcus aureus diseases. Kurlenda J; Grinholc M Acta Biochim Pol; 2012; 59(2):171-84. PubMed ID: 22577619 [TBL] [Abstract][Full Text] [Related]
5. In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections. Desbois AP; Gemmell CG; Coote PJ Int J Antimicrob Agents; 2010 Jun; 35(6):559-65. PubMed ID: 20206480 [TBL] [Abstract][Full Text] [Related]
6. Virulence factors and genetic characteristics of methicillin-resistant and -susceptible Staphylococcus aureus isolates in Myanmar. Aung MS; Urushibara N; Kawaguchiya M; Aung TS; Mya S; San T; Nwe KM; Kobayashi N Microb Drug Resist; 2011 Dec; 17(4):525-35. PubMed ID: 21834665 [TBL] [Abstract][Full Text] [Related]
7. Dehydrosqualene Desaturase as a Novel Target for Anti-Virulence Therapy against Gao P; Davies J; Kao RYT mBio; 2017 Sep; 8(5):. PubMed ID: 28874472 [No Abstract] [Full Text] [Related]
8. Therapies against virulence products of Staphylococcus aureus and Pseudomonas aeruginosa. Wiener-Kronish JP; Pittet JF Semin Respir Crit Care Med; 2011 Apr; 32(2):228-35. PubMed ID: 21506059 [TBL] [Abstract][Full Text] [Related]
9. Community-acquired methicillin-resistant Staphylococcus aureus--a review of literature. Okesola AO Afr J Med Med Sci; 2011 Jun; 40(2):97-107. PubMed ID: 22195376 [TBL] [Abstract][Full Text] [Related]
10. Is there any rationale for treatment of Staphylococcus aureus infections with antimicrobials that are determined to be ineffective in vitro? Uekötter A; Peters G; Becker K Clin Microbiol Infect; 2011 Aug; 17(8):1142-7. PubMed ID: 21672081 [TBL] [Abstract][Full Text] [Related]
11. Anti-infective drug development for MRSA. Daniel A Methods Mol Biol; 2014; 1085():311-31. PubMed ID: 24085703 [TBL] [Abstract][Full Text] [Related]
12. Staphylococcus aureus nasal carriage, virulence traits, antibiotic resistance mechanisms, and genetic lineages in healthy humans in Spain, with detection of CC398 and CC97 strains. Lozano C; Gómez-Sanz E; Benito D; Aspiroz C; Zarazaga M; Torres C Int J Med Microbiol; 2011 Aug; 301(6):500-5. PubMed ID: 21570348 [TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management of community-associated MRSA infections in children. Long CB; Madan RP; Herold BC Expert Rev Anti Infect Ther; 2010 Feb; 8(2):183-95. PubMed ID: 20109048 [TBL] [Abstract][Full Text] [Related]
14. Mutations in agr do not persist in natural populations of methicillin-resistant Staphylococcus aureus. Shopsin B; Eaton C; Wasserman GA; Mathema B; Adhikari RP; Agolory S; Altman DR; Holzman RS; Kreiswirth BN; Novick RP J Infect Dis; 2010 Nov; 202(10):1593-9. PubMed ID: 20942648 [TBL] [Abstract][Full Text] [Related]
15. Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin. French GL J Antimicrob Chemother; 2006 Dec; 58(6):1107-17. PubMed ID: 17040922 [TBL] [Abstract][Full Text] [Related]
16. Redeploying β-Lactam Antibiotics as a Novel Antivirulence Strategy for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections. Waters EM; Rudkin JK; Coughlan S; Clair GC; Adkins JN; Gore S; Xia G; Black NS; Downing T; O'Neill E; Kadioglu A; O'Gara JP J Infect Dis; 2017 Jan; 215(1):80-87. PubMed ID: 28077586 [TBL] [Abstract][Full Text] [Related]
17. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Micek ST Clin Infect Dis; 2007 Sep; 45 Suppl 3():S184-90. PubMed ID: 17712745 [TBL] [Abstract][Full Text] [Related]
18. ω-Hydroxyemodin limits staphylococcus aureus quorum sensing-mediated pathogenesis and inflammation. Daly SM; Elmore BO; Kavanaugh JS; Triplett KD; Figueroa M; Raja HA; El-Elimat T; Crosby HA; Femling JK; Cech NB; Horswill AR; Oberlies NH; Hall PR Antimicrob Agents Chemother; 2015 Apr; 59(4):2223-35. PubMed ID: 25645827 [TBL] [Abstract][Full Text] [Related]